학술논문

EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 127건 | 목록 1~20
Kim WS; Sungkyunkwan University School of Medicine, Samsung Medical Center Division of Hematology-Oncology, Seoul, South Korea. wskimsmc@gmail.com.; Kim TM; Seoul National University Hospital, Seoul National University Cancer Research Institute, Seoul, South Korea.; Cho SG; Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.; Jarque I; Hematology Department, Hospital Universitari i Politècnic La Fe, Centro de Investigación Biomédica en Red de Cáncer-CIBERONC, Valencia, Spain.; Iskierka-Jażdżewska E; Copernicus Memorial Hospital, Department of General Hematology, Medical University of Łódź, Łódź, Poland.; Poon LM; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Prince HM; Epworth HealthCare and University of Melbourne, Melbourne, Victoria, Australia.; Zhang H; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Cao J; Fudan University Shanghai Cancer Center, Shanghai, China.; Zhang M; Department of Oncology, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.; Tessoulin B; Hematology Department, Nantes University Hospital, Nantes, France.; Oh SY; Dong-A University Hospital, Busan, South Korea.; Lim F; Singapore General Hospital, Singapore, Singapore.; Carpio C; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Autonomous University of Barcelona (UAB), Barcelona, Spain.; Tan TD; Hematology and Medical Oncology, Koo Foundation Sun Yat Sen Cancer Center, Taipei City, Taiwan.; Ayyappan S; University of Iowa Hospital and Clinics, Iowa City, IA, USA.; Gutierrez A; Department of Hematology, Hospital Universitario Son Espases, IdISBa, Palma, Spain.; Cai J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Ufkin M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Shariff S; Regeneron UK, Ltd., Uxbridge, UK.; Brouwer-Visser J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Chaudhry A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Mohamed H; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Ambati S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Walewski J; Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warszawa, Poland.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Kim WS; Sungkyunkwan University School of Medicine, Samsung Medical Center Division of Hematology-Oncology, Seoul, South Korea. wskimsmc@gmail.com.; Kim TM; Seoul National University Hospital, Seoul National University Cancer Research Institute, Seoul, South Korea.; Cho SG; Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.; Jarque I; Hematology Department, Hospital Universitari i Politècnic La Fe, Centro de Investigación Biomédica en Red de Cáncer-CIBERONC, Valencia, Spain.; Iskierka-Jażdżewska E; Copernicus Memorial Hospital, Department of General Hematology, Medical University of Łódź, Łódź, Poland.; Poon LM; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Prince HM; Epworth HealthCare and University of Melbourne, Melbourne, Victoria, Australia.; Zhang H; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Cao J; Fudan University Shanghai Cancer Center, Shanghai, China.; Zhang M; Department of Oncology, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.; Tessoulin B; Hematology Department, Nantes University Hospital, Nantes, France.; Oh SY; Dong-A University Hospital, Busan, South Korea.; Lim F; Singapore General Hospital, Singapore, Singapore.; Carpio C; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Autonomous University of Barcelona (UAB), Barcelona, Spain.; Tan TD; Hematology and Medical Oncology, Koo Foundation Sun Yat Sen Cancer Center, Taipei City, Taiwan.; Ayyappan S; University of Iowa Hospital and Clinics, Iowa City, IA, USA.; Gutierrez A; Department of Hematology, Hospital Universitario Son Espases, IdISBa, Palma, Spain.; Cai J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Ufkin M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Shariff S; Regeneron UK, Ltd., Uxbridge, UK.; Brouwer-Visser J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Chaudhry A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Mohamed H; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Ambati S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Walewski J; Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warszawa, Poland.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. Electronic address: gabriel9@snu.ac.kr.; Taszner M; Department of Haematology and Transplantology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.; Novelli S; Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Cho SG; Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.; Villasboas JC; Mayo Clinic, Rochester, USA.; Merli M; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Jiménez-Ubieto A; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Tessoulin B; Hematology Department, Nantes University Hospital, Nantes, France.; Poon LM; Hematology Oncology National University Hospital, Singapore, Singapore.; Tucker D; Department of Hematology, Royal Cornwall Hospital, Truro, UK.; Walewski J; Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warsaw, Poland.; Yi S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Song Y; Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China.; Chong G; Department of Medical Oncology, and Clinical Haematology, Olivia Newton-John Cancer Centre, Heidelberg, Australia.; Bachy E; Department of Hematology, Lyon Sud Hospital, Lyon, France; Lymphoma Immuno-Biology (LIB) team, Inserm U1111, CIRI, Lyon, France.; Guidez S; Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France.; Alonso A; Hospital Universitario Quiron Salud Madrid, Madrid, Spain.; Jagadeesh D; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, USA.; Zhang W; Hematology Department, Peking Union Medical College Hospital, Beijing, China.; Magnano L; Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Iskierka-Jażdżwska E; Copernicus Memorial Hospital, Department of General Hematology, Medical University of Łódź, Łódź, Poland.; Tani M; Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy.; Shen B; Regeneron Pharmaceuticals, Inc., Tarrytown, USA.; Uppala A; Regeneron Pharmaceuticals, Inc., Tarrytown, USA.; Zhu M; Regeneron Pharmaceuticals, Inc., Tarrytown, USA.; Shariff S; Regeneron UK Ltd., Uxbridge, UK.; Brouwer-Visser J; Regeneron Pharmaceuticals, Inc., Tarrytown, USA.; Chaudhry A; Regeneron Pharmaceuticals, Inc., Tarrytown, USA.; Mohamed H; Regeneron Pharmaceuticals, Inc., Tarrytown, USA.; Ambati S; Regeneron Pharmaceuticals, Inc., Tarrytown, USA.; Luminari S; Division of Hematology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.; Matasar M; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ.; Allan JN; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY.; Ansell SM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.; Barnes JA; Department of Medicine, Hematology and Oncology Division, Massachusetts General Hospital Cancer Center, Boston, MA.; Arnason JE; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.; Michot JM; Departement D'Innovation Therapeutique et D'Essais Precoces, Gustave Roussy Cancer Campus, Villejuif, France.; Goldschmidt N; Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; O'Brien SM; Division of Hematology/Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange, CA.; Abadi U; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Hematology, Meir Medical Center, Kfar Saba, Israel.; Avivi I; Department of Hematology, Ichilov University Hospital, Tel Aviv, Israel.; Cheng Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Flink DM; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Zhu M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Brouwer-Visser J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Chaudhry A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Mohamed H; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Ambati S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY.; Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Zhu M; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Madia P; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Crawford A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Brouwer-Visser J; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Krueger P; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Haber L; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Peterman M; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Uldrick TS; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Miller E; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Davis JD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Retter MW; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
Academic Journal
Weinstock M; Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Elavalakanar P; Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Bright S; Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Ambati SR; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Brouwer-Visser J; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Pourpe S; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Fiaschi N; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Jankovic V; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Thurston G; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Deering RP; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Chaudhry A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.; Joyce R; Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Arnason J; Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Brouwer-Visser, J.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어